hai Biomarkers in Cancer Conferences | Meetings | Events | Symposiums | ConferenceSeries

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

 

Recommended Conferences for Biomarkers in Cancer

Biomarkers in Cancer


As per available reports about Biomarkers 10 relevant journals, 10 Conferences, 2 workshops are presently dedicated exclusively to biomarkers in cancer and about 2,070 articles are being published on biomarkers in cancer.

cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology. Ideally, such biomarkers can be assayed in non-invasively collected biofluids like blood or serum
 

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.


Scope and Importance:

While numerous challenges exist in translating biomarker research into the clinical space; a number of gene and protein based biomarkers have already been used at some point in patient care; including, Liver Cancer, Chronic Myeloid Leukemia, Breast/Ovarian Cancer, V600E (Melanoma/Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Colorectal Cancer, Non-small-cell lung carcinoma, Breast Cancer, Prostate Specific Antigen and Prostate Cancer.
The National Cancer Institute (NCI), in particular, defines biomarker as a: “A biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease”.
This symposium should be of interest to physicians practicing all subspecialties of oncology, as well as professionals involved in human genetics , genetic counseling, and molecularly-based clinical trials design and implementation. Around 30 – 35 workshops and symposium will be held in 2015 in all around the world these include “ Keystone symposium” “2014 Gastrointestinal Cancers Symposium”

Market Analysis:

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.

International symposium and workshops :
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
ASRT Radiation Therapy Conference, October 18-20, 2015, San Antonio, Texas.
Annual Radiotherapy Conference, January 30 – February 1, 2015, Thistle Bristol City Centre, The Grand Broad Street, England
RTi3: Radiation Therapy Conference 2015, March 6 – 7, 2015, Chestnut Conference Centre, Toronto
Creating a Better Future For Cancer Patients Worldwide , Mar30- Apr 02 , 2015 , Pentagon City – Arlington, VA, United States 

List of Best International Conferences :
Pancreatic and Colorectal Cancer
March 29-30, 2016 Atlanta, USA.
Blood Malignancies and Treatment
April 18-20, 2016 Dubai, UAE.
Gynecologic Oncology
May 19-21, 2016 San Antonio, USA.
Antimicrobial Agents and Chemotherapy
June 6-7, 2016 Dallas, USA.
Cancer Diagnostics Conference & Expo
June 13-15, 2016 Rome, Italy.
10th Global Oncologists Annual Meeting
July 11-13, 2016 Cologne, Germany.
11th Asia-Pacific Oncology and Oncologists Meeting
July 11-13, 2016 Kuala Lumpur, Malaysia.
Melanoma and Carcinoma
July 14-15, 2016 Brisbane, Australia.
Neuro Onclogy,
July 21-23, 2016 Brisbane, Australia.
Thyroid Cancer and Treatment
Aug 1-3, 2016 Toronto, Canada.
Oral, Mouth and Throat Cancer
Aug 18-20, 2016 Portland, Oregon.
Molecular & Cancer Biomarkers
Sept 15-17, 2016 Berlin, Germany.
Cervical Cancer
Sept 22-23, 2016 Vienna, Austria.
Radiation Oncology
Sep 26-28, 2016 Valencia, Spain.
12th Euro Global Summit on Cancer Therapy
Sept 26-28, 2016 London, UK.
13th Global Oncologists Summit and Cancer Therapy
Oct 17-19, 2016 Dubai, UAE.
Mesothelioma
Nov 3-4, 2016 Valencia, Spain.
 Leukemia and Bone marrow Transplantation
Nov 10-12, 2016 Istanbul, Turkey.
14th Cancer Therapy
Dec 8-10, 2016 Baltimore, USA.
2nd Prostate Cancer and Treatment Conference
May 5-7,2016, Chicago, USA.

Relevant Society and Associations
American Society for Radiation Oncology.
American Cancer Society.                               
Cancer Research UK.
British Association of Urological Surgeons (BAUS).
National Cancer Institute.
Cancer society of New Zealand.
American society of clinical oncology.
Cancer Research foundation.
Cancer Research Institute.
Urological Association of Asia and Iranian.
Canadian Cancer Society.

List of Companies
IBA Proton Therapy.
Sun Nuclear.
Elekta, Inc.
RaySearch Laboratories.
Modus Medical Devices Inc.
PI (Physik Instrumente) L.P. Piezo Nanopositioning.
Accuray.
VARIAN Medical Systems Particle Therapy GmbH.
CIRS.
LifeLine Software, Inc./RadCalc.

This page will be updated regularly.

This page was last updated on November 5, 2024

Conference Series Destinations